Examining Choice Architecture for Genetic Testing Decisions
NCT ID: NCT04372888
Last Updated: 2024-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1012 participants
INTERVENTIONAL
2020-03-11
2020-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Expanded Prenatal Testing Options and Informed Choice
NCT00505596
Informed Choice Regarding Invasive Prenatal Testing
NCT00514553
Usefulness of Home Pregnancy Testing
NCT00390754
Impact of Predictive Genetic Testing
NCT03988504
Evaluation of a Decision Assisting Tool for Prenatal Testing
NCT00686062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
rare genetic disease
Hypothetical scenario 1: rare, life-altering genetic condition (congenital hypogonadotropic hypogonadism)
choice decision frame
active choice for genetic testing
opt-in decision frame
"gain" frame for genetic testing
opt-out decision frame
"loss" frame for genetic testing
enhanced choice (context) decision frame
consequences of genetic testing
enhanced choice (norms) decision frame
social norms for genetic testing
enhanced choice (affect) decision frame
commitments for genetic testing
common genetic disease
Hypothetical scenario 2: common, life-threatening genetic condition (hereditary breast and ovarian cancer)
choice decision frame
active choice for genetic testing
opt-in decision frame
"gain" frame for genetic testing
opt-out decision frame
"loss" frame for genetic testing
enhanced choice (context) decision frame
consequences of genetic testing
enhanced choice (norms) decision frame
social norms for genetic testing
enhanced choice (affect) decision frame
commitments for genetic testing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
choice decision frame
active choice for genetic testing
opt-in decision frame
"gain" frame for genetic testing
opt-out decision frame
"loss" frame for genetic testing
enhanced choice (context) decision frame
consequences of genetic testing
enhanced choice (norms) decision frame
social norms for genetic testing
enhanced choice (affect) decision frame
commitments for genetic testing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew A Dwyer, PhD
Role: PRINCIPAL_INVESTIGATOR
Boston College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston College
Chestnut Hill, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dwyer AA, Shen H, Zeng Z, Gregas M, Zhao M. Framing Effects on Decision-Making for Diagnostic Genetic Testing: Results from a Randomized Trial. Genes (Basel). 2021 Jun 20;12(6):941. doi: 10.3390/genes12060941.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20.205.01e
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.